Iovance Biotherapeutics (IOVA) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Iovance Biotherapeutics (IOVA) Company Statistics | The Fly

Iovance Biotherapeutics

· IOVA

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

6.545 B

+2.56%

General

Market Cap: $6.55B
Enterprise Value: $6.55B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 116.30%
Operating Margin: -92.72%
Net Profit Margin: -89.09%
FCF Margin: -91.21%
ROA: -31.62%
ROE: -40.51%
ROIC: -36.60%
Current Ratio: 4.35
Debt-to-Equity: 0.06
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 20.36
P/FCF: —
P/B: 8.99
EV/EBITDA: -24.93

Growth

Rev 1Y: 60.60%
Rev 1Y Fwd Est: 55.82%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR)

Income Statement (TTM)

Revenue: $324.97M
Gross Margin: 116.30%
Operating Expenses: $679.25M
Operating Income: -$301.31M
Net Profit: -$289.52M

Balance Sheet

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $110.77M
Working Capital: $357.41M
Total Assets: $915.53M
Net Debt: -$64.77M
Total Liabilities: $179.49M
Total Equity: $736.05M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$264.18M
Cash Flow from Investing: -$44.87M
Cash Flow from Financing: $287.85M
Free Cash Flow: -$296.4M
Capital Expenditures: $32.21M